The pricing gap on pharmaceuticals is wild. Same drug runs you $10 in London but hits $130 in New York? That's nearly a 13x markup. Policy shifts are targeting these disparities hard—the goal is dragging that $130 price point down to $20 or so. The math is pretty straightforward when you see the numbers laid out. These kinds of price corrections don't just affect healthcare; they ripple through consumer spending, inflation expectations, and overall market sentiment. If pharma margins compress significantly, it changes how investors think about healthcare stocks and purchasing power globally. Worth watching how this reshapes cost structures across industries.